Kiyatec

Greenville, SC · Founded 2005 · Privately Held (backing)

Developer of patient-specific three-dimensional cell culture testing services designed to predict therapeutic response for cancer treatment selection. Kiyatec is based in Greenville, SC and was founded in 2005. Its last reported valuation was $62.1 million in May 2023. It has raised $32.9 million across 4 recorded rounds; the latest was a $250,000 seed round in Oct 2024.

Last reported valuation
$62.1M
Oct 2026
Priced at
—
Total raised
$32.9M
Last round
Seed Round
Oct 2024

Kiyatec key facts

as of Oct 2026
  • Developer of patient-specific three-dimensional cell culture testing services designed to predict therapeutic response for cancer treatment selection.
  • Kiyatec is valued at approximately $62.1M as of Oct 2026 (last reported valuation).
  • It has raised $32.9M across 4 recorded rounds; the latest was Seed Round ($250K) in Oct 2024.
  • Notable investors include Labcorp Venture Fund, SC Launch, Seae Ventures, Atlanta Technology Angels, Abhishek Narang — 20 tracked in total.
  • Kiyatec has filed 10 Form Ds with the SEC since 2012, most recently Nov 2024 ($250K sold to 1 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$62.1M

Kiyatec's last reported valuation, May 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Kiyatec with a free account
  • ·The complete investor list: 20 names
  • ·Watch Kiyatec: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Kiyatec funding rounds

4 rounds
Oct 2024Seed Round$250KSEC filing▮
Nov 2022Early Stage VC$18.1MSEC filing▮
Feb 2019Early Stage VC$5.3MSEC filing▮
Nov 2015Seed Round$3.1MSEC filing▮

Kiyatec valuation

Kiyatec's last reported valuation was $62.1 million in May 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Kiyatec raised?

Kiyatec has raised $32.9 million across 4 recorded rounds since 2015. The largest was a $5.3 million early-stage round in Feb 2019; the most recent was a $250,000 seed round in Oct 2024.

Kiyatec has filed 10 Form Ds with the SEC since 2012, most recently in Nov 2024 ($250,000 sold to 1 investor).

Kiyatec investors

20 investors are on record for Kiyatec, including Labcorp Venture Fund, SC Launch, Seae Ventures and Atlanta Technology Angels. The seed round in Oct 2024 drew 1 investor.

About Kiyatec

Developer of patient-specific three-dimensional cell culture testing services designed to predict therapeutic response for cancer treatment selection. The company's testing technology evaluates individual patients' tumour responses ex vivo, enabling oncologists to identify effective therapies and avoid likely non-responders before treatment begins.

Sector
Healthcare
HQ
Greenville, SC, United States
Founded
2005
Employees
15
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.